Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial.

Cheuk-Chun SzetoJack Kit-Chung NgWinston Wing-Shing FungGordon Chun-Kau ChanPhyllis Mei-Shan ChengKa-Bik LaiWing-Fai PangKai-Ming ChowChi-Bon LeungPhilip Kam-Tao Li

Published in: Clinical kidney journal (2021)

In patients with PD-related peritonitis, extending the antibiotic therapy for 1 extra week beyond the ISPD protocol should not be recommended. Extending the treatment does not reduce the risk of relapsing or recurrent peritonitis episodes but rather is associated with a higher risk of repeat peritonitis episodes.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
multiple sclerosis
ejection fraction
randomized controlled trial
disease activity
rheumatoid arthritis
systemic lupus erythematosus
combination therapy
patient reported